BRAF MUTATION-RELATED TUMORS
Clinical trials for BRAF MUTATION-RELATED TUMORS explained in plain language.
Never miss a new study
Get alerted when new BRAF MUTATION-RELATED TUMORS trials appear
Sign up with your email to follow new studies for BRAF MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-stage study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, or related mutations). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. …
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New drug combo aims to shrink deadly thyroid tumors before surgery
Disease control Recruiting nowThis early-phase study tests whether giving two drugs (XL092 and cemiplimab) before surgery can safely help remove anaplastic thyroid cancer completely in people with a specific gene type (BRAF V600E wildtype). About 12 adults with this rare, aggressive cancer will receive the dr…
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:07 UTC